Literature DB >> 16640617

Comparison of cytokine plasma levels in human African trypanosomiasis.

David Courtin1, Vincent Jamonneau, Jean-François Mathieu, Mathurin Koffi, Jacqueline Milet, Claude Sese Yeminanga, Victor Kande Betu Kumeso, Gérard Cuny, Constantin Miaka Mia Bilengue, André Garcia.   

Abstract

BACKGROUND: Immunological studies suggest that human African trypanosomiasis (HAT) is associated with inflammatory responses. A better understanding of the complex cytokine interactions regulating HAT infections is essential to elucidate the mechanisms of generalized immunosuppression.
METHOD: We determined levels of interleukin (IL)-2, IL-4, IL-6, IL-10, tumour necrosis factor (TNF)-alpha and interferon (IFN)-gamma protein levels in plasma samples from three groups of individuals from the Democratic Republic of Congo: (i) HAT cases; (ii) seropositive individuals for whom parasite detection was negative and (ii) controls.
RESULTS: Plasma levels of six cytokines were significantly higher in HAT cases than in both controls (P<0.003) and seropositive individuals (P<0.016). IL-2 and IL-10 concentrations were significantly lower (P<0.02) in the seropositive group than in the control one.
CONCLUSION: Human African trypanosomiasis leads to the development of strong cytokine responses, indicating the potential involvement of IL-2 and IL-10 in the phenomenon of seropositivity without parasitological confirmation. This strongly suggests the involvement of immunity in this particular aspect of HAT epidemiology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16640617     DOI: 10.1111/j.1365-3156.2006.01612.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  10 in total

1.  Prototypical anti-inflammatory cytokine IL-10 prevents loss of IGF-I-induced myogenin protein expression caused by IL-1beta.

Authors:  Klemen Strle; Robert H McCusker; Rodney W Johnson; Samantha M Zunich; Robert Dantzer; Keith W Kelley
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-02-12       Impact factor: 4.310

2.  Spatially and genetically distinct African Trypanosome virulence variants defined by host interferon-gamma response.

Authors:  Lorna Maclean; Martin Odiit; Annette Macleod; Liam Morrison; Lindsay Sweeney; Anneli Cooper; Peter G E Kennedy; Jeremy M Sternberg
Journal:  J Infect Dis       Date:  2007-10-25       Impact factor: 5.226

Review 3.  Human host determinants influencing the outcome of Trypanosoma brucei gambiense infections.

Authors:  B Bucheton; A MacLeod; V Jamonneau
Journal:  Parasite Immunol       Date:  2011-08       Impact factor: 2.280

4.  The miRNA and mRNA Signatures of Peripheral Blood Cells in Humans Infected with Trypanosoma brucei gambiense.

Authors:  Smiths Lueong; Smiths Leong; Gustave Simo; Mamadou Camara; Vincent Jamonneau; Jacques Kabore; Hamidou Ilboudo; Bruno Bucheton; Jörg D Hoheisel; Christine Clayton
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

5.  A morphological approach to the diagnosis of protozoal infections of the central nervous system.

Authors:  Leila Chimelli
Journal:  Patholog Res Int       Date:  2011-07-14

6.  Genetic control of resistance to Trypanosoma brucei brucei infection in mice.

Authors:  Matyáš Síma; Helena Havelková; Lei Quan; Milena Svobodová; Taťána Jarošíková; Jarmila Vojtíšková; Alphons P M Stassen; Peter Demant; Marie Lipoldová
Journal:  PLoS Negl Trop Dis       Date:  2011-06-07

7.  Interleukin (IL)-6 and IL-10 Are Up Regulated in Late Stage Trypanosoma brucei rhodesiense Sleeping Sickness.

Authors:  Charles D Kato; Vincent P Alibu; Ann Nanteza; Claire M Mugasa; Enock Matovu
Journal:  PLoS Negl Trop Dis       Date:  2015-06-19

8.  Plasma cytokine profiles associated with rhodesiense sleeping sickness and falciparum malaria co-infection in North Eastern Uganda.

Authors:  Julius Nsubuga; Charles Drago Kato; Ann Nanteza; Enock Matovu; Vincent Pius Alibu
Journal:  Allergy Asthma Clin Immunol       Date:  2019-10-30       Impact factor: 3.406

9.  Plasma cytokines quantification among Trypanosoma brucei rhodesiense sleeping sickness cases and controls in Rumphi, Malawi.

Authors:  Kelita Kamoto; Arthur Chiwaya; Peter Nambala; Pricilla Chammudzi; Edward Senga; John Chisi; Enock Matovu; Janelisa Musaya
Journal:  Malawi Med J       Date:  2021-12       Impact factor: 0.875

Review 10.  The role of cytokines in the pathogenesis and staging of Trypanosoma brucei rhodesiense sleeping sickness.

Authors:  Charles D Kato; Enock Matovu; Claire M Mugasa; Ann Nanteza; Vincent P Alibu
Journal:  Allergy Asthma Clin Immunol       Date:  2016-01-22       Impact factor: 3.406

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.